Who is sponsoring NCT06333405?

NCT06333405 is sponsored by Medical University of Warsaw.

What drugs are being tested in NCT06333405?

Interventions in NCT06333405: Fecal Microbiota Transplantation.

What condition does NCT06333405 study?

NCT06333405 studies Necrotizing Enterocolitis.

Is NCT06333405 still recruiting?

NCT06333405 is currently status unknown. Last updated 27 March 2024.

Last reviewed 2024-03-27 · How we verify

NCT06333405

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fecal Microbiota Transplantation (FMT) as a Prophylaxis of Necrotizing Enterocolitis (NEC) - Clinical Study

Status unknown NA Last updated 27 March 2024

What this trial tests

NA trial testing Fecal Microbiota Transplantation in Necrotizing Enterocolitis in 20 participants. Status unknown.

Timeline

1 May 2024

Primary endpoint
31 January 2025

31 January 2025

Quick facts

Lead sponsor	Medical University of Warsaw
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	20
Start date	1 May 2024
Primary completion	31 January 2025
Estimated completion	31 January 2025
Sites	1 location across Poland

Drugs / interventions tested

Fecal Microbiota Transplantation — full drug profile →

Conditions studied

Necrotizing Enterocolitis — all drugs for Necrotizing Enterocolitis →

Sponsor

Medical University of Warsaw

Who can join

Adults 24 Weeks to 36 Weeks, any sex, with Necrotizing Enterocolitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to assess the safety of fecal microbiota transplantation (FMT) as a preventive method for the development of Necrotizing enterocolitis (NEC) in a group of premature infants. This is the first stage of a clinical trial testing the effectiveness of FMT in NEC, the aim of which is to examine the safety profile and analyze all side effects.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Review: microbial metabolites - a key to address gut inflammation and barrier dysfunction in the premature infant.
Robertson KM, Cermack K, Woodruff T, Carter SR, et al · · 2025 · cited 1× · PMID 40887742 · DOI 10.1080/19490976.2025.2551117
Fecal Microbiota Transplantation (FMT) as a Prophylaxis of Necrotizing Enterocolitis (NEC)-Protocol for a Safety Study.
Bieganska EA, Wolski M, Zarlenga M, Bilinski J, et al · · 2026 · PMID 41901284 · DOI 10.3390/ph19030437

Verify or expand the search:

Other trials of Fecal Microbiota Transplantation

Trials testing the same drug.

NCT07464392 — FMT for the Prevention of Infectious Complications in Patients With Moderately Severe and Severe Acute Pancreatitis · NA · recruiting
NCT07454408 — Evaluation of the Outcome of Fecal Microbiota Transplantation · Phase 1, PHASE2 · not yet recruiting
NCT07463248 — PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line · Phase 2 · not yet recruiting
NCT07042438 — Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Expo · Phase 2 · recruiting
NCT06744751 — A Study on the Effects of Combined FMT on Gut Microbiota and Eating Disorder Symptoms in AN · NA · not yet recruiting

Other recruiting trials for Necrotizing Enterocolitis

Currently open trials in the same condition.

NCT06681129 — Study of Normal Intestinal Development and Disease in Premature and Term Neonates · recruiting
NCT06672913 — Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study · NA · recruiting
NCT06908239 — Milk Temperature Control and Necrotizing Enterocolitis Risk in Extremely Preterm Infants · NA · active not recruiting
NCT06032676 — Qualitative Study of Surgeons With Prospective Patient Follow-up · recruiting
NCT05272579 — PrePhage - Faecal Bacteriophage Transfer for Enhanced Gastrointestinal Tract Maturation in Preterm Infants · EARLY_PHASE1 · recruiting

Other Medical University of Warsaw trials

Trials by the same sponsor.

NCT07515768 — TAVI Without On-Site Cardiac Surgery in Poland: A Randomized Multicenter Trial Protocol · NA · not yet recruiting
NCT07511907 — Routine Intraoperative White Test for Bile Leak Detection in Liver Resection · NA · not yet recruiting
NCT07498660 — PRP Injection Into the Sacroiliac Joint After Ipsilateral THA: Effects on Early Recovery and Function (SIJ-THA Randomize · NA · not yet recruiting
NCT07398898 — Use of Augmented Reality Glasses and Noise-Cancelling Headphones to Reduce Dental Anxiety in Adult Patients · NA · recruiting
NCT07237204 — 15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06333405 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medical University of Warsaw
Last refreshed: 27 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06333405.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing